Skip to main content
. 2022 Dec 16;58(12):1862. doi: 10.3390/medicina58121862

Table 4.

Epidemiological, clinical and pathological patterns of patients diagnosed with vaginal and vulvar cancer (n = 21).

Pre-Pandemic (2019) Pandemic with High Restrictions (2020) Pandemic Recovery (2021) p
Number of patients, n 8 8 5
Age at diagnosis, median (IQR; Min-Max), years 71.0 (21; 54–86) 80.0 (17; 72–96) 68.0 (42; 32–89) 0.095
Postmenopausal status, n (%) 8 (100.0) 8 (100.0) 3 (60.0) 0.029 *
Histological type, n (%)
Squamous cell carcinoma
Melanoma
Paget´s disease of the vulva
Basal cell carcinoma
 
4 (50.0)
1 (12.5)
1 (12.5)
2 (25.0)
 
7 (87.5)
0 (0.0)
0 (0.0)
1 (12.5)
 
5 (100.0)
0 (0.0)
0 (0.0)
0 (0.0)
0.440
Tumor staging1, n (%)
Initial stage (IA, IB)
Advanced stage (II-IV)
Unknown
 
5 (62.5)
0 (0.0)
3 (37.5)
 
5 (62.5)
3 (37.5)
0 (0.0)
 
2 (40.0)
3 (60.0)
0 (0.0)
0.051
Time between first MDTM and treatment initiation, median (IQR; Min-Max), days 27.0 (-; 27–74) 27.0 (23; 13–43) 49.0 (73; 21–131) 0.354
Therapeutic management, n (%)
Chemoradiotherapy
Surgery 2
Palliative
No treatment 3
 
0 (0.0)
3 (37.5)
0 (0.0)
5 (62.5)
 
0 (0.0)
5 (62.5)
1 (12.5)
2 (25.0)
 
2 (40.0)
3 (60.0)
0 (0.0)
0 (0.0)
0.053
Hospitalization days, median (Min-Max) 21.0 (-; 3–44) 30.0 (37; 3–45) 9.0 (-; 3–12) 0.448
Intra- and post-operative complications 4, n (%) 1 (33.3) 4 (80.0) 1 (33.3) 0.302
Time between surgery and histological assessment, median (Min-Max), days 50.0 (-; 16–90) 30.0 (26; 12–42) 31.0 (-; 25–35) 0.517

Legend: IQR—interquartile range; MDTM—multidisciplinary team meeting. 1 Tumor staging was assessed using the revised International Federation of Gynecology and Obstetrics (FIGO) Classification 2009 [19] and TNM Classification of Malignant Tumors (TNM) 2017 [22]. 2 In two cases, patients were submitted to neoadjuvant chemoradiotherapy. 3 Patients under surveillance, lost to follow-up or death. 4 Pre-pandemic (2019): infection and dehiscence of the surgical wound (n = 1); pandemic with high restrictions (2020): vulvar hemorrhage (n = 1), infection and dehiscence of the surgical wound (n = 3); pandemic recovery (2021): infection and dehiscence of the surgical wound (n = 1). * Statistically significant differences for a significance level of 0.05.